Skip to content
Daniel Castellano· @cdanicas · X·· 2 days agoScore70

KN-866

Body

🎯 Starting the GU oral session! #ESMO26 @JensBedke presented the ph3 study in MIBC KN-866
A negative study of Cis-Gem + Pembro vs Cis-Gem periop.🤷‍♂️
What about NIAGARA study? 🤨 @OncoAlert @myESMO @DrFelixGuerrero @GuardConsortium @UroTarget

381 views · 11 likes · 8 reposts · 0 replies

Source: Daniel Castellano · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org